| Name | Title | Contact Details |
|---|---|---|
George Brandes |
Senior Vice President, Product Development | Profile |
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
Promises Behavioral Health is a company that provides addiction and mental health treatment at treatment facilities across the country.
TriHealth is the healthcare system that formed as a partnership between Good Samaritan Hospital and Bethesda Hospital, Inc. Through acute care hospitals and more than 80 locations, TriHealth provides a wide range of clinical, educational, preventive an...
Upfront`s Care Traffic Control platform proactively reassures and directs patients to the safest and most relevant care options within the health system.
InterGroup Services Corporation is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.